SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,560.00    110.00 (2.47%)
Bid:
4,530.00
Ask:
4,590.00
Spread: 60.00 (1.325%)
Market Cap: £303.73m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Trading Update

20 Jul 2016 07:00

RNS Number : 6631E
Judges Scientific PLC
20 July 2016
 

Press Release

20 July 2016

 

Judges Scientific Plc

("Judges Scientific" or "the Group")

Trading Update

 

Further to the AGM statement released on 25 May 2016, the Directors of Judges Scientific, a group involved in the buy and build of scientific instrument businesses, update shareholders and the market regarding the Group's trading performance during the first half of the current financial year.

The Group's results for the six-month period to 30 June 2016 will include a full contribution from Armfield Limited (against 23 weeks in the first half of 2015) and the post-acquisition contribution from CoolLED Limited and Dia-Stron Limited which were acquired in the first quarter of 2016. "Organic" in this statement excludes both the performance of Armfield and the more recent acquisitions.

Order intake

For the third year in a row, order intake in the first quarter was weak; this lasted until the end of May and was followed by a healthy rebound with five consecutive weeks of strong bookings narrowing the decline in Organic order intake for the first half to only 1.6% below 2015. The Organic order book finished the first half at 10.7 weeks of sales against 11.7 weeks at 30th June 2015 and 11.4 weeks at the beginning of the period.

Following a very strong year in 2015, Armfield experienced low order intake until the end of May and, although it also recovered in June, it is well below the first half of 2015. Management believes that this reduction in orders has been influenced by the weak price of oil and other commodities and their impact on public funding in many developing economies.

For the Group as a whole, order intake was down 3.4% compared with the first half of 2015 and the order book stood at 10.6 weeks at 30th June 2016.

First Half Performance

The timing of the recovery in order intake prevented the improved bookings from translating into a satisfactory sales performance for the period to 30 June 2016; this was compounded by production issues at one of the companies in our vacuum segment. As a consequence revenues, EBIT and earnings per share for the first half will be down on 2015.

Full Year Outlook

The recent revival in order intake and the positive impact of a weaker pound post Brexit give the Board confidence that the second half will produce better results, however it will be difficult to claw back the underperformance of the first half, as indicated in the AGM statement. The Board now believes that earnings per share for the full year will be substantially below market expectations.

 

- Ends -

 

For further information please contact:

 

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 203 829 6970

 

Shore Capital (Nominated Adviser & Broker)

 

Stephane Auton

Edward Mansfield

Tel: +44 (0) 20 7408 4090

 

Media enquiries:

Abchurch (Financial Public Relations)

 

Canace Wong

Nessyah Hart

Julian Bosdet

Tel: +44 (0) 20 7398 7714

www.abchurch-group.com

 

 

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 14 businesses acquired since it was first admitted to AIM in 2003.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.

 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

 

The Group's companies predominantly operate in niche end markets, with long term growth fundamentals and resilient margins.

 

For further information, please visit www.judges.uk.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVDDAIALIR
Date   Source Headline
7th Jun 20133:24 pmRNSDirector/PDMR Shareholding
29th May 20135:17 pmRNSResult of AGM
10th May 20134:06 pmRNSDirector/PDMR Shareholding
12th Apr 20133:30 pmRNSIssue of Equity
9th Apr 201311:59 amRNSDirector/PDMR Shareholding
22nd Mar 20137:00 amRNSFinal Results
8th Mar 201311:30 amRNSNotice of Results
7th Mar 20132:41 pmRNSDirector/PDMR Shareholding
8th Feb 20133:54 pmRNSDirector/PDMR Shareholding
24th Jan 20137:00 amRNSTrading Statement
17th Jan 201310:55 amRNSIssue of Equity
14th Jan 20132:43 pmRNSIssue of Equity
8th Jan 20133:24 pmRNSDirector/PDMR Shareholding
17th Dec 20122:11 pmRNSIssue of Equity
10th Dec 20123:28 pmRNSDirector/PDMR Shareholding and issue of equity
4th Dec 20123:06 pmRNSIssue of Equity
21st Nov 20127:00 amRNSTrading Statement
8th Nov 20125:22 pmRNSDirector/PDMR Shareholding
5th Nov 20122:24 pmRNSDirector/PDMR Shareholding
5th Nov 201210:14 amRNSDirector's Details
29th Oct 20122:22 pmRNSDirector/PDMR Shareholding
9th Oct 201212:05 pmRNSDirector/PDMR Shareholding
3rd Oct 20122:28 pmRNSHolding(s) in Company
25th Sep 20126:28 pmRNSHolding(s) in Company
25th Sep 20127:00 amRNSHalf Yearly Report
7th Sep 20123:19 pmRNSDirector/PDMR Shareholding
6th Sep 201211:31 amRNSNotice of Results
31st Aug 20129:52 amRNSHolding(s) in Company
24th Aug 20127:00 amRNSDirector/PDMR Shareholding
22nd Aug 20123:44 pmRNSHolding(s) in Company
21st Aug 20127:00 amRNSDirector/PDMR Shareholding
8th Aug 20123:13 pmRNSDirector/PDMR Shareholding
23rd Jul 20125:34 pmRNSDirector/PDMR Shareholding
18th Jul 20127:00 amRNSTrading Statement
9th Jul 20125:43 pmRNSDirector/PDMR Shareholding
29th Jun 201212:17 pmRNSDirector/PDMR Shareholding
29th Jun 20127:00 amRNSDirector/PDMR Shareholding
22nd Jun 20127:00 amRNSDirector/PDMR Shareholding
21st Jun 20125:17 pmRNSHolding(s) in Company
7th Jun 20124:36 pmRNSDirector/PDMR Shareholding
30th May 20125:16 pmRNSResult of AGM
22nd May 20126:18 pmRNSDirector/PDMR Shareholding
17th May 20123:31 pmRNSHolding(s) in Company
17th May 20123:16 pmRNSHolding(s) in Company
16th May 20125:14 pmRNSHolding(s) in Company
11th May 201212:07 pmRNSDirector/PDMR Shareholding
10th May 201210:00 amRNSIssue of Equity
9th May 201211:33 amRNSHolding(s) in Company
23rd Apr 20125:24 pmRNSExercise of Options
18th Apr 20125:46 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.